The global foot and ankle devices market is projected to grow at a compound annual growth rate (CAGR) of approximately 8% from 2026 to 2034, reaching a market size of $9.2 billion by 2034. This growth is driven by the increasing prevalence of foot and ankle conditions such as arthritis, fractures, and tendon injuries, alongside a rising burden of diabetes-related complications like diabetic foot ulcers. Advances in medical technology, including minimally invasive procedures and innovative implants, are also fueling demand. North America currently leads the market, supported by advanced healthcare infrastructure and high adoption of new technologies, while emerging markets in Asia-Pacific are expanding rapidly due to improving healthcare access and rising awareness.
Johnson & Johnson reported strong Q2 sales of $584 million for Spravato, a nasal spray for treatment-resistant depression, signaling robust market potential for psychedelic drugs. Jefferies highlights this growth supports the commercial viability of ...
Johnson & Johnson reported solid Q2 2026 results, achieving 6.6% annual revenue growth driven by strong Pharma and MedTech divisions. The company maintains a portfolio of over 15 blockbuster drugs and a promising pipeline, supporting its status as a ...
Johnson & Johnson reported better-than-expected Q2 2026 results with adjusted EPS of $2.90, surpassing estimates, and revenue of $25.31 billion, driven by strong pharmaceutical sales. Key growth came from the Innovative Medicine segment, with notable...
The FTSE 100 dropped 23 points to 10,506, pressured by mining stocks reacting to China's slower-than-expected 4.3% GDP growth in Q2, its weakest in three years. European markets also declined, while US futures rose, led by tech. PayPal shares surged ...
US stock futures rose after a softer-than-expected Consumer Price Index (CPI) report reduced the chances of a Federal Reserve rate hike in July. The market now awaits today's Producer Price Index (PPI) data, which could either confirm easing inflatio...
